Kumiko Ishiguro

Shinjuku, 1628666, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

National survey of patients with neuromuscular disease and COVID-19 in Japan.

National survey of patients with neuromuscular disease and COVID-19 in Japan.

Journal: Brain & development
Published: February 08, 2026

Nonrandomized Allocation of Steroid Therapy in Patients With Fukuyama Congenital Muscular Dystrophy: Study Protocol for a Phase II Clinical Trial.

Nonrandomized Allocation of Steroid Therapy in Patients With Fukuyama Congenital Muscular Dystrophy: Study Protocol for a Phase II Clinical Trial.

Journal: Neuropsychopharmacology reports
Published: February 24, 2025

Challenges in genetic counseling for RYR1-related myopathies.

Challenges in genetic counseling for RYR1-related myopathies.

Journal: Brain & development
Published: January 20, 2025

Cross-Sectional Study of the Association Between Plasma Brain Natriuretic Peptide Levels and Left Ventricular Shortening Fraction in Fukuyama Congenital Muscular Dystrophy.

Cross-Sectional Study of the Association Between Plasma Brain Natriuretic Peptide Levels and Left Ventricular Shortening Fraction in Fukuyama Congenital Muscular Dystrophy.

Journal: The Tohoku journal of experimental medicine
Published: November 20, 2024

Urinary prostaglandin D2 and E2 metabolites are elevated with disease severity in patients with Fukuyama congenital muscular dystrophy.

Urinary prostaglandin D2 and E2 metabolites are elevated with disease severity in patients with Fukuyama congenital muscular dystrophy.

Journal: Scientific reports
Published: August 22, 2024

Rare mosaic variant of GJA1 in a patient with a neurodevelopmental disorder.

Rare mosaic variant of GJA1 in a patient with a neurodevelopmental disorder.

Journal: Human genome variation
Published: October 19, 2023

Author Correction: Efficacy of steroid therapy for Fukuyama congenital muscular dystrophy.

Author Correction: Efficacy of steroid therapy for Fukuyama congenital muscular dystrophy.

Journal: Scientific reports
Published: August 02, 2022

Efficacy of steroid therapy for Fukuyama congenital muscular dystrophy.

Efficacy of steroid therapy for Fukuyama congenital muscular dystrophy.

Journal: Scientific reports
Published: May 26, 2021

Urinary titin as a biomarker in Fukuyama congenital muscular dystrophy.

Urinary titin as a biomarker in Fukuyama congenital muscular dystrophy.

Journal: Neuromuscular disorders : NMD
Published: August 12, 2020

A short form of gross motor function measure for Fukuyama congenital muscular dystrophy.

A short form of gross motor function measure for Fukuyama congenital muscular dystrophy.

Journal: Brain & development
Published: September 30, 2019

Renal dysfunction is rare in Fukuyama congenital muscular dystrophy.

Renal dysfunction is rare in Fukuyama congenital muscular dystrophy.

Journal: Brain & development
Published: March 21, 2018

Characteristic findings of skeletal muscle MRI in caveolinopathies.

Characteristic findings of skeletal muscle MRI in caveolinopathies.

Journal: Neuromuscular disorders : NMD
Published: January 30, 2018
Showing 1-12 of 14

Last Updated: 09/26/2026